EGFR and neoplasm: In a Canadian validation study of plasma EGFR T790M testing, plasma testing showed more T790M‐positive results (62%) than tumor biopsy alone (49%), with 75% sensitivity using highly sensitive methods such as ddPCR, next‐generation sequencing, and RT‐PCR.26